Shoulder arthroplasty following solid organ transplant: A systematic review and meta-analysis

Patel, Akshar V.; Duey, Akiro H.; Stevens, Andrew J.; Vaghani, Parth A.; Cvetanovich, Gregory L.; Bishop, Julie Y.; Rauck, Ryan C.

doi:10.1016/j.jor.2022.11.015

Cited by 3 publications

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The study reported 90-day higher readmission rates, medically related complications, and transfusion requirements in the SOT group; however no difference in LOS, infection, or surgical complications [8]. Few additional studies have published data on shoulder arthroplasty in organ transplant patients as well, including a systemic review by Patel et al, which comprised only 71 all-type shoulder arthroplasties [9][10][11][12][13]. However, examination of this topic specifically among RSA patients remains largely unexplored.…”

Section: Introductionmentioning

confidence: 99%

The Influence of Solid Organ Transplant on Inpatient Complications, Length of Stay, and Hospital Costs in Reverse Shoulder Arthroplasty Patients

Sohn,

Do,

Sambandam

et al. 2024

Cureus

View full text Add to dashboard Cite

Introduction: With innovations in transplant medicine and longer life expectancies in solid organ transplant (SOT) recipients, the incidence of shoulder arthroplasty is predictably rising in this population. Reverse shoulder arthroplasty (RSA) has become increasingly popular due to advances in prosthetic design with expanded indications. While previous studies have examined shoulder arthroplasty in SOT patients, information specifically related to RSA patients is largely unexplored. We aim to analyze the demographics and characteristics of SOT patients who have undergone RSA while assessing inpatient complication rates, length of stay (LOS), and hospital costs in these patients compared to a matched cohort of non-transplant patients. Methods: The National Inpatient Sample (NIS) Database was utilized to identify all patients undergoing RSA from 2016 to 2019. We generated propensity-matched groups based on pre-operative variables (diabetes, tobacco use, sex, age, and obesity) to compare complications, LOS, and inpatient costs between the SOT and control groups. T-tests and Chi-squared tests were performed where appropriate and odds ratios were calculated. Results: We identified 59925 patients who underwent RSA. Among those, 59769 patients (99.7%) did not have a SOT and 156 patients (0.26%) had a history of SOT. Patients in the SOT group were younger than the control group (67.0 versus 71.4 years, p<0.001). The SOT group were more likely males compared to the control group (53.8% versus 39.3%, p<0.001). Following 1:1 matching, there were 156 patients in each group. The SOT group had a higher risk of acute renal failure (ARF) compared to the control group (OR 9.41, 95% CI (2.13-41.49), p<0.001). The LOS (p<0.001) and inpatient costs (p<0.001) were higher in the SOT group. Conclusion: For RSA, SOT patients are younger and more likely male compared to those without SOT. Inpatient medical and surgical complications are similar between SOT and non-SOT patients, except SOT patients have a higher risk of ARF. SOT patients tend to have longer LOS and higher inpatient costs than non-SOT patients.

show abstract